HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack. (Q54532891)

31 May 2018

title

HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack. (English)

1 reference

31 May 2018

0 references

Wenjing Cui

1

1 reference

31 May 2018

Yu Zhao

2

1 reference

31 May 2018

Changliang Shan

3

1 reference

31 May 2018

Guangyao Kong

4

1 reference

31 May 2018

Nan Hu

5

1 reference

31 May 2018

Yiwen Zhang

6

1 reference

31 May 2018

Shuai Zhang

7

1 reference

31 May 2018

Weiying Zhang

8

1 reference

31 May 2018

Yingyi Zhang

9

1 reference

31 May 2018

Xiaodong Zhang

10

1 reference

31 May 2018

Lihong Ye

11

1 reference

31 May 2018

language of work or name

English

0 references

publication date

27 January 2012

1 reference

31 May 2018

published in

FEBS Letters

1 reference

31 May 2018

volume

586

1 reference

31 May 2018

issue

6

1 reference

31 May 2018

page(s)

766-771

1 reference

31 May 2018

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Immune evasion of tumor cells using membrane-bound complement regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Expression of complement regulating factors in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistanc

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.039

10.1016/J.FEBSLET.2012.01.039

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

PubMed ID

22293503

1 reference

31 May 2018